Biotech & Pharma
Strategy & Commercialization

Our team of pharma business consultants provide deep knowledge in critical areas such as company and portfolio strategies, fundraising pitch materials, platform or program opportunity-feasibility assessments, new product planning, value-based pricing and market access, and product launch preparations.

Our Pharmaceutical Strategy & Commercialization Services

Business Plans
& Fundraising Support

A sound strategy is essential to healthcare investors at all stages of corporate development.


Gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.

New Product

Work with our experts to craft product strategies that are compelling to patients, providers, and payers.


Be ready for launch, on time and on budget, with the right people, processes and information for success.

Our strategy & commercialization capabilities

Whether you need guidance charting your optimal path to market, technical or market insight to prioritize your R&D portfolio, or strategic support to help you best position your biotech or program for a fundraising round, we can assist. Our consultants average 20-30 years of industry experience and bring significant first-hand knowledge to every project. 

Our core team leverages our Expert Network, which contains over 90 expert strategy and commercialization
 consultants who specialize in specific technologies and disease areas, allowing us to provide precisely relevant expertise across the below functional disciplines:

  • Business Analysis/Forecasting
  • Business Plans/Investor Pitch Decks
  • Commercial Strategy/Marketing
  • Market Access

  • Market Research 
  • Sales and Operations
  • Supply Chain


  • Autoimmune/Immunology
  • Cardiovascular
  • Central Nervous System
  • Congenital Disorders
  • Dermatology/Aesthetics
  • Digestive/GI
  • Ear
  • Endocrine and Metabolic
  • Fibrosis
  • Genitourinary Diseases
  • Haematology
  • Infectious Disease
  • Inflammation/Pain
  • Injuries and Trauma
  • Musculoskeletal
  • Non-medical
  • Oncology
  • Ophthalmology
  • Orphan Diseases
  • Respiratory
  • Urology (non-onc)
  • Women’s Health

Explore our Strategy & Commercialization Services

Contact Us

Reach out today for more information on our strategy & commercialization services.

Case Studies

Glycan biomarker discovery market research in North America

Challenge A glycan biomarker research company with a proprietary platform offering biomarker discovery and characterization, diagnostic development and commercialization asked Alacrita to...

Business plan and fundraising for cell therapy company

Challenge An early stage, European cell therapy company focused on developing novel off-the-shelf NK cell therapy solutions for the treatment of a variety of cancers had developed a...

Investor pitch deck for biotech developing non-opioid analgesic

Challenge A start-up US biotech developing a non-opioid analgesic drug and delivery device was preparing to raise its first round of external funding. They engaged Alacrita to help frame...

Business plan for opioid overdose detection device

Challenge Our client was a start-up looking to raise external venture capital funding for development of a biosensor for early detection of opioid overdose. The company had drafted a...

Commercial viability of a bacterial biomarker test

Challenge A leading UK university and an executive agency of the DoH were collaboratively developing a rapid (30 min) bacterial ID and antimicrobial resistance test platform. The technology...

Sales forecast in metastatic colorectal and gastric cancer

Challenge An international oncology drug development company is developing a bispecific product, currently in preclinical development. As an initial evaluation, our client wanted to...